logo
[breadcrumb_custom]

Tag: UROV Stock

Trading Signals

Urovant Sciences (UROV)’ Largest Shareholder set to Acquire UROV for $584 Million

Sumitovant Biopharma, the largest shareholder of Urovant already owns 72% of the company and is now set to acquire it entirely. Shares of Urovant Sciences Ltd. (UROV) spiked on Friday after the company announced the acquisition deal with Sumitovant Biopharma. UROV soared up to 93.48% trading at $16.02. The stock jumped from a previous close of $8.28 to $15.98 at the opening of the last trading session. The stock was on a heavy volume with the shares trading around 10 million. On November 12, Urovant Sciences entered into a definitive merger agreement with Sumitovant Biopharma to acquire the outstanding common stock shares